CS955382A2 - Zpusob vyroby ergolinylovych sloucenin substituovanych v poloze 8 dusikem - Google Patents

Zpusob vyroby ergolinylovych sloucenin substituovanych v poloze 8 dusikem

Info

Publication number
CS955382A2
CS955382A2 CS829553A CS955382A CS955382A2 CS 955382 A2 CS955382 A2 CS 955382A2 CS 829553 A CS829553 A CS 829553A CS 955382 A CS955382 A CS 955382A CS 955382 A2 CS955382 A2 CS 955382A2
Authority
CS
Czechoslovakia
Prior art keywords
sub
sup
substituovanych
sloucenin
ergolinylovych
Prior art date
Application number
CS829553A
Other languages
English (en)
Other versions
CS235098B2 (en
Inventor
Gregor Dr Haffer
Gerhard Dr Sauer
Helmut Dr Wachtel
Herbert Dr Schneider
Ulrich Dr Eder
Hans Peter Dr Lorenz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS955382A2 publication Critical patent/CS955382A2/cs
Publication of CS235098B2 publication Critical patent/CS235098B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS829553A 1981-12-23 1982-12-22 Method of orgolinyl compounds production ortosubstituted by nitrogen CS235098B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813151912 DE3151912A1 (de) 1981-12-23 1981-12-23 Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
CS955382A2 true CS955382A2 (en) 1984-02-13
CS235098B2 CS235098B2 (en) 1985-04-16

Family

ID=6150011

Family Applications (1)

Application Number Title Priority Date Filing Date
CS829553A CS235098B2 (en) 1981-12-23 1982-12-22 Method of orgolinyl compounds production ortosubstituted by nitrogen

Country Status (18)

Country Link
US (1) US4826852A (cs)
EP (2) EP0082808B1 (cs)
JP (1) JPS58150593A (cs)
AT (1) ATE27458T1 (cs)
AU (1) AU570621B2 (cs)
CA (1) CA1319684C (cs)
CS (1) CS235098B2 (cs)
DD (1) DD208619A5 (cs)
DE (2) DE3151912A1 (cs)
DK (1) DK163240C (cs)
ES (1) ES8400115A1 (cs)
GR (1) GR78410B (cs)
HU (1) HU191623B (cs)
IE (1) IE56541B1 (cs)
IL (1) IL67545A (cs)
RO (2) RO85270B (cs)
SU (1) SU1313348A3 (cs)
YU (1) YU282382A (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400333A (nl) * 1983-02-16 1984-09-17 Sandoz Ag Moederkoornalkaloiden, hun bereiding en hun toepassing.
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
DE3413657A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergoline
DE3413659A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 2-substituierte ergolin-derivate
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
DE3528576A1 (de) * 1985-08-06 1987-02-19 Schering Ag Verfahren zur herstellung von ergolin-thioharnstoffen
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
GB0307377D0 (en) * 2003-03-31 2003-05-07 Merad Pharmaceuticals Ltd Ergoline derivatives
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
JP5248510B2 (ja) * 2006-10-04 2013-07-31 エム アンド ペー パテント アクツィエンゲゼルシャフト 神経伝達物質の鼻腔投与のための徐放性送達システム
EP2083008A1 (en) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergoline derivatives as selective radical scavengers for neurons
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533698A (en) * 1950-12-12 Urethanes containing the lysergic
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
DE1212097B (de) * 1962-09-05 1966-03-10 Sdruzeni Podnikuu Pro Zdravotn Verfahren zur Herstellung von N-[D-1, 6-Dimethylisoergolenyl-(8)]-N', N'-dialkylharnstoffen
FR1339406A (fr) * 1962-11-23 1963-10-04 Farmaceutici Italia Procédé de préparation de nouveaux dérivés de 6-méthylergoline pi et de 1, 6-diméthylergoline pi
BR6915443D0 (pt) * 1969-07-18 1973-03-13 Farmaceutici Italia Processo para a preparacao de derivados de ergolina
CH573936A5 (cs) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1573621A (en) * 1976-01-02 1980-08-28 Sandoz Ltd Acylated 6-methyl-8a-amino-ergoline i compounds
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
DE3127845A1 (de) * 1980-07-25 1982-04-22 Sandoz-Patent-GmbH, 7850 Lörrach Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und ihre anwendung bei der therapeutischen behandlung
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
GB2112382B (en) * 1981-11-06 1985-03-06 Erba Farmitalia Ergoline derivatives
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate

Also Published As

Publication number Publication date
YU282382A (en) 1986-12-31
IL67545A0 (en) 1983-05-15
IE56541B1 (en) 1991-08-28
EP0082808A1 (en) 1983-06-29
RO87945A (ro) 1986-09-30
ES518482A0 (es) 1983-11-01
GR78410B (cs) 1984-09-27
JPH0352463B2 (cs) 1991-08-12
DK163240B (da) 1992-02-10
DK566982A (da) 1983-06-24
DE3151912A1 (de) 1983-06-30
EP0185392A2 (en) 1986-06-25
EP0185392A3 (en) 1987-05-13
CS235098B2 (en) 1985-04-16
RO85270B (ro) 1984-10-30
US4826852A (en) 1989-05-02
AU570621B2 (en) 1988-03-24
IE823051L (en) 1983-06-23
ES8400115A1 (es) 1983-11-01
JPS58150593A (ja) 1983-09-07
SU1313348A3 (ru) 1987-05-23
IL67545A (en) 1986-09-30
DK163240C (da) 1992-06-29
DE3276433D1 (en) 1987-07-02
DD208619A5 (de) 1984-04-04
EP0082808B1 (en) 1987-05-27
RO85270A (ro) 1984-09-29
HU191623B (en) 1987-03-30
AU9146882A (en) 1983-06-30
ATE27458T1 (de) 1987-06-15
CA1319684C (en) 1993-06-29

Similar Documents

Publication Publication Date Title
CS955382A2 (en) Zpusob vyroby ergolinylovych sloucenin substituovanych v poloze 8 dusikem
ZA857824B (en) Substituted propane-phosphonous acid compounds
GB8801722D0 (en) Differential bit line clamp
EP0057546A3 (en) Sulfonylurea n-oxides
EP0207158A4 (en) ANTIASTHMA PREPARATION CONTAINING 8,11,14,17-EICOSATETRAENOIC ACID.
ES8801796A1 (es) Procedimiento para la obtencion de derivados del acido piridin-3-carboxilico
AU6212786A (en) Boom-mounted drilling apparatus slewable through 360 degrees
ZA822854B (en) 4'-halo-substituted sucrose derivatives
AU575022B2 (en) Antiviral 5-halovinyl-2'-deoxyuridines
AU2454284A (en) 2h(1)benzoxepino(5,4-b)1,4-oxazines
GR79822B (cs)
DE3275091D1 (en) Derivatives of m.139,603 useful as growth promotors
ZA828877B (en) Therapeutically useful 3,7a-diazacyclohepta(j,k)fluorene derivatives
PT78107A (en) 2h-<1>benzoxepino<5,4-b>-1,4 oxazine derivatives
ES8202811A1 (es) Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina
FI92394B (fi) 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste
Park Problem of theaged & its action-General action
PH25608A (en) 3-amino-tetrahydro-isoquinoline
FI874677A7 (fi) Laekemedel anvaendbart vid behandling av magsaor.
AU543274B2 (en) 11,15-dihydroxy-9-oxo-13,18-prostadienoic acid
IE841800L (en) 15,16-methylene-17-pregna-4,5-diene-21-carboxylic acid salts
SU1272951A1 (ru) Абонентский комплект для автоматических телефонных станций
IE871642L (en) 4-(3'trifluoromethylphenoxy)-benzoylacetic acid derivatives.
NZ192609A (en) 2,3,5,6,11,11b-hexahydroimidazo(1',5':1,2)-or1,2,3,4,6,7,12,12b-octahydropyrimido(1',6':1,2)pyrido(3,4-b)indole(1,3 or 2,4)-diones
IE812154L (en) 1-aza-5-oxabicyclo £4,2,0| octene derivatives